Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasFoundations — epidemiologic methods for psychiatry

Psych Vivas · Foundations — epidemiologic methods for psychiatry

Epidemiologic methods for psychiatry — structured clinical viva

Fellowship viva on prevalence vs incidence, association vs causation, bias/confounding, PAF, and screening base rates.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are in a FRANZCP/MRCPsych-style viva. The examiner says: 'A newspaper reports that schizophrenia is rare because few people are admitted each year. A trainee shows you a case-control study where cannabis use was more common among people with first-episode psychosis (OR 2.2) and concludes cannabis causes 50% of psychosis. A GP wants to use a psychosis risk questionnaire with sensitivity 85% and specificity 85% to screen all 18-year-olds in schools where true prevalence of the target state is under 1%. Defend the correct frequency measure for community burden, dismantle the causal overclaim, explain confounding versus effect modification, and walk through predictive values at low prevalence. Be ready for follow-ups on person-time, PAF assumptions, Hill criteria, and STROBE.'

Interpretation

Reveal interpretation

Newspaper claim. Admission counts are service-use rates, not community incidence or prevalence. They depend on bed supply, thresholds, pathways, and help-seeking. Community burden needs population-based surveys (period prevalence for current caseload; incidence cohorts for new-onset rates) with clear case definitions.[1]

Case-control OR 2.2 → “causes 50%”. Case-control designs efficiently study associations for psychosis onset but face selection and information bias and cannot alone prove causation.[2][3] An OR is not a PAF. A PAF near 50% would require a valid causal RR, correct exposure prevalence, and minimal bias/confounding — assumptions that must be stated and often fail.[4] Reverse causation and shared vulnerability (confounding) are live alternatives; temporality and triangulation matter (Hill weight-of-evidence).[5][2]

Confounding vs effect modification. Confounding: common cause distorts the exposure–outcome association — control by design/analysis if measured.[2][8] Effect modification: effect differs across strata — report strata rather than “adjust away.” DAGs help avoid adjusting mediators or colliders.[8]

School screening. At prevalence under 1%, even Sn/Sp of 85% generate many more false positives than true positives among screen-positives → low PPV, stigma and assessment burden.[6] Screening needs programme criteria and pathways, not a questionnaire alone.

Follow-ups. Person-time denominators for incidence rates with unequal follow-up.[1] STROBE improves transparent reporting of observational methods — it does not certify causal truth.[7]

Key points

Admissions ≠ community epidemiology

Hospital flow reflects system behaviour as much as disease occurrence.

OR is not PAF

Association measures do not automatically become population impact.

Base rate rules PPV

Low-prevalence school screening fails on predictive value even with “good” Sn/Sp.
[1] [4] [6]

References

  1. [1]Grimes DA, Schulz KF An overview of clinical research: the lay of the land Lancet, 2002.PMID 11809203
  2. [2]Grimes DA, Schulz KF Bias and causal associations in observational research Lancet, 2002.PMID 11812579
  3. [3]Grimes DA, Schulz KF Case-control studies: research in reverse Lancet, 2002.PMID 11844534
  4. [4]Rockhill B, Newman B, Weinberg C Use and misuse of population attributable fractions Am J Public Health, 1998.PMID 9584027
  5. [5]Hill AB The environment and disease: association or causation? Proc R Soc Med, 1965.PMID 14283879
  6. [6]Altman DG, Bland JM Diagnostic tests 2: Predictive values BMJ, 1994.PMID 8038641
  7. [7]von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement Lancet, 2007.PMID 18064739
  8. [8]Greenland S, Pearl J, Robins JM Causal diagrams for epidemiologic research Epidemiology, 1999.PMID 9888278